Css LLC Allakos Inc. Call Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $73,152 - $141,264	-14,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $123,120 - $1.61 Million	14,400 New	14,400 $140,000
Q1 2021 May 17, 2021	SELL	$109.73 - $153.66 $131,676 - $184,392	-1,200 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $35,232 - $64,552	-800 Reduced 40.0%	1,200 $86,000
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $44,490 - $93,390	-1,000 Reduced 33.33%	2,000 $89,000
Q4 2019 Feb 14, 2020	BUY	$66.49 - $137.73 $199,469 - $413,189	3,000 New	3,000 $285,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $110M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.